Anti-lipopolysaccharide factor (32-51)[Y2A], L-2

General Information


DRACP ID  DRACP03758

Peptide Name   Anti-lipopolysaccharide factor (32-51)[Y2A], L-2

Sequence  HARIKPTFRRLKWKYKGKFW

Sequence Length  20

UniProt ID  P07086 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C129H196N38O23

Absent amino acids  CDEMNQSV

Common amino acids  K

Mass  298628

Pl  12.3

Basic residues  9

Acidic residues  0

Hydrophobic residues  7

Net charge  9

Boman Index  -5667

Hydrophobicity  -131.5

Aliphatic Index  44

Half Life 
  Mammalian: 3.5 hour
  Yeast: 10 min
  E.coli: >10 hour

Extinction Coefficient cystines  12490

Absorbance 280nm  657.37

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23401744

Title  The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12315

DRACP is developed by Dr.Zheng's team.